EUVIMEDEUVIMED entdecken
Crossref

Allosteric activation of pyruvate carboxylase by Dracoflavan B2 enhances endothelial energy metabolism to attenuate myocardial infarction

Chen Hong, Han Li, Rui-Yue Liu, Ran Wang, Yun-Jiao Sun, Yang-Li Huang, Tian-Tian Wei, Peng-Fei Tu, Ke-Wu Zeng, Jun Li

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Chen Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China; Modern Research Center for Traditional Chinese Medic…. Hauptthemen laut MEDLINE: Pyruvate Carboxylase, Myocardial Infarction, Energy Metabolism, Flavonoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Myocardial infarction (MI) is a life-threatening cardiovascular event characterized by ischemic necrosis and endothelial cell (EC) dysfunction, which exacerbates tissue injury and impairs repair. Mitochondrial dysfunction, a central contributor to MI pathogenesis, disrupts energy metabolism and promotes oxidative stress. Pyruvate carboxylase (PC), a key mitochondrial anaplerotic enzyme, replenishes TCA cycle intermediates and sustains cellular bioenergetics, yet its role in endothelial protection during MI remains unclear. PURPOSE: This study aims to investigate the cardioprotective effects and underlying mechanisms of Dracoflavan B2 (DB2), a natural compound derived from Daemonorops draco Bl., with a focus on its mitochondrial-targeted action in endothelial cells under ischemic injury. METHODS: The protective effect of DB2 was evaluated both in vitro using oxygen-glucose deprivation (OGD)-induced EC injury models and in vivo in a murine MI model. A photoaffinity probe incorporating a diazirine crosslinker and clickable handle was developed to identify direct cellular targets of DB2. Chemogenetic profiling, enzymatic assays, and metabolic flux analysis were employed to elucidate the molecular interactions and functional consequences of DB2 on PC activity and mitochondrial metabolism. RESULTS: DB2 significantly ameliorated OGD-induced EC injury and improved cardiac function in MI mice. Target identification revealed PC as a direct binding protein of DB2. Mechanistically, DB2 acted as an allosteric agonist of PC, promoting a conformational shift that enhanced oxaloacetate production, replenished TCA cycle intermediates, and restored mitochondrial oxidative phosphorylation and ATP synthesis. DB2 treatment counteracted OGD-induced metabolic disruption and sustained endothelial bioenergetic homeostasis. CONCLUSION: Our findings demonstrate that DB2 protects against myocardial ischemic injury by targeting PC and enhancing mitochondrial anaplerotic flux, thereby preserving endothelial function and myocardial energetics. This study identifies DB2 as a novel allosteric PC agonist with translational potential for the treatment of MI and highlights mitochondrial metabolic reprogramming as a promising therapeutic strategy in cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pyruvate CarboxylaseMyocardial InfarctionEnergy MetabolismFlavonoidsAnimalsMiceAllosteric RegulationMice, Inbred C57BLEndothelial CellsMaleHumansMitochondriaCardiotonic AgentsOxidative StressHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

Dracoflavan B(2)Endothelial protectionMitochondrial energy metabolismMyocardial infarctionPyruvate carboxylaseTargeted therapy

Substanzen

Pyruvate CarboxylaseCardiotonic AgentsFlavonoids

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China; Modern Research Center for Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing Univer…
  • School of Bioengineering, Tianjin University of Science and Technology, Tianjin 300457, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100080, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100080, China. Electronic address: pengfeitu@bjmu.edu.cn.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100080, China; Department of Integration of Chinese and Western Medicine, School of Basic Medical Scien…

Förderung

  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Hong, C., Li, H., Liu, R. Y., Wang, R., Sun, Y. J., Huang, Y. L., Wei, T. T., Tu, P. F., Zeng, K. W., & Li, J. (2026). Allosteric activation of pyruvate carboxylase by Dracoflavan B2 enhances endothelial energy metabolism to attenuate myocardial infarction. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158145

Vancouver

Hong C, Li H, Liu RY, Wang R, Sun YJ, Huang YL, et al. Allosteric activation of pyruvate carboxylase by Dracoflavan B2 enhances endothelial energy metabolism to attenuate myocardial infarction. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158145

BibTeX
@article{Hong2026,
  author = {Hong, Chen and Li, Han and Liu, Rui-Yue and Wang, Ran and Sun, Yun-Jiao and Huang, Yang-Li and Wei, Tian-Tian and Tu, Peng-Fei and Zeng, Ke-Wu and Li, Jun},
  title = {Allosteric activation of pyruvate carboxylase by Dracoflavan B2 enhances endothelial energy metabolism to attenuate myocardial infarction},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158145}
}
Kostenlos starten →